Kirk Sigmon and Hengyi Jiang of Banner & Witcoff Ltd. examine recent policy shifts in both China and the U.S. that signal a ...

Five robotics-driven stocks - PATH, EMR, TRMB, OMCL and LECO - are set to gain traction heading into late 2025.

A recent study from Oregon State University estimated that more than 3,500 animal species are at risk of extinction because ...

Birla Opus Paints, a division of Aditya Birla Group’s Grasim Industries, launched an aerosol paint range, One Aero, that is ...

- Apple brings the App Store to the web, allowing users to browse apps on all platforms After years of waiting, Apple has ...

Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL) has been the odd one out in the Magnificent Seven for a while. The stock didn’t make ...

Gcore, the global AI, cloud, network, and security solutions provider, today announced the launch of Everywhere AI. This ...

FDA feedback enables CervoMed to proceed with proposed endpoints, patient enrichment strategy, and other key aspects of Phase 3 trial design to ...

BCC Research examines how investor confidence, smart automation, and AI-enabled quality control are reshaping the global food and beverage sector.”Boston, Nov. 04, 2025 (GLOBE NEWSWIRE) -- As ...

In this comprehensive guide, Sophie demonstrates DIY tire repair techniques with ease, focusing on inner tube repair and ...

A familiar blue pot has long anchored bathroom shelves, yet a second blue rival is quietly tempting baskets across France.

Takeda has announced the completion of its 7-year, Phase III TIDES clinical trial (NCT02747927) evaluating the dengue vaccine, Qdenga. Along with an exploratory analysis of a booster dose, TIDES data ...